0001950047-24-004229.txt : 20240529 0001950047-24-004229.hdr.sgml : 20240529 20240529165305 ACCESSION NUMBER: 0001950047-24-004229 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240529 DATE AS OF CHANGE: 20240529 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC CENTRAL INDEX KEY: 0000914475 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330525145 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 000-22705 FILM NUMBER: 24999235 BUSINESS ADDRESS: STREET 1: 6027 EDGEWOOD BEND COURT CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 617-7600 MAIL ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: SHERWIN STEPHEN A CENTRAL INDEX KEY: 0001079462 ORGANIZATION NAME: STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O CELL GENESYS, INC. STREET 2: 500 FORBES BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 144 1 primary_doc.xml 144 0001079462 XXXXXXXX LIVE 0000914475 NEUROCRINE BIOSCIENCES, INC. 000-22705 6027 Edgewood Bend Court San Diego CA 92130 (858) 617-7600 STEPHEN A SHERWIN Director Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

40000 5338563.00 100637227 05/29/2024 NASDAQ Common 05/29/2024 Stock Option Exercise Issuer N 40000 05/29/2024 Cash Y 05/29/2024 02/28/2024 /s/ Stephen Alan Sherwin